Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD）
Clinical trial NCT05795517 · COMPLETED
Trial details
- NCT number
- NCT05795517
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-26
- Primary completion
- 2024-02-20
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.